In 2018, I started my own corporate governance consultancy.

I hold a degree in law (lic. iur HSG) from the University of St. Gallen and I am a Swiss attorney-at-law and a notary. I also hold a Master degree (LL.M.) in International Business Law from London School of Economics, London.

I am Co-Director of the European Corporate Governance Council of the Conference Board, Counsel to the law firm Binder Legal (https://www.binderlegal.ch/en/home/) and General Counsel of TargImmune Therapeutics AG. I cooperate with HCM Hostettler & Company (http://www.hcm.com/en/home/home.html) and Georgeson (http://www.georgeson.com/uk).

I teach Corporate Governance at the University of St. Gallen’s Executive M.B.L. program and I am member of the Advisory Board of the Corporate Governance Competence Centre of the University of St. Gallen.

Until February 2018, I was Senior Advisor Corporate Governance to the Board of Novartis and Secretary to the Executive Committee of Novartis. My prior roles at Novartis included being Secretary to the Board of Novartis and Head Corporate Law & Governance of Novartis.

I was former Co-Chairman of the European Corporate Governance Council, a member of the International Corporate Governance Network and a member of the OECD BIAC Corporate Governance Committee.

I joined Novartis in 2004 from DHL, where I was General Counsel DHL Air & Ocean. Before the merger of DHL and Danzas I was the General Counsel of Danzas, being responsible for legal services, compliance and risk management.

Previous to DHL/Danzas, I spent four years as Corporate Legal Counsel at Roche Holding in Basel, where I advised on corporate law and finance, mergers and acquisitions transactions and international commercial contracts.

Prior to Roche, I spent three years with the Swiss law firm Froriep Renggli, providing counsel on a wide range of corporate and international trade law, working from the Zürich and London office.

I started my career working as in-house counsel, first in the banking and then in auditing industry.